Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2102307Generated: October 26, 2026

1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → 5-(5-Chloro-2-fluoro-phenyl)-3-chloromethyl-[1,2,4]oxadiazole

https://huagongshe.com/reaction/2102307

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 15908—
Reactant1-HydroxybenzotriazoleHCID 75771—
Reactant3-(3-Amino-1,2,4-oxadiazol-5-yl)-1-azabicyclo(2.2.1)heptaneHCID 163938—
Reactant5-Chloro-2-fluorobenzoic acidHCID 2736537—
ReactantHCID 178511097HCID 178511097—
SolventDimethylformamideHCID 6228—
Product5-(5-Chloro-2-fluoro-phenyl)-3-chloromethyl-[1,2,4]oxadiazoleHCID 4312021056.3%

Reaction Steps

The acyclic intermediate was prepared from 2-fluoro-5-chlorobenzoic acid (550 mg, 3.15 mmol), EDCI (665 mg, 3.47 mmol), HOBT (469 mg, 3.47 mmol) and 2-chloro-N-hydroxy-acetamidine (377 mg, 3.47 mmol) in DMF (10 mL). To effect cyclization to oxadiazole, DMF (15 mL) was added to the intermediate residue and the mixture was heated for 1 hour. The product was purified by flash column chromatography using 10% ethyl acetate in hexane afforded the title compound (438 mg, 56% yield over 2 steps, white solid). 1H NMR (CDCl3) δ (ppm): 8.16 (m, 1H), 7.58 (m, 1H), 7.29 (m, 1H), 4.72 (s, 3H).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07576077B2
Source datasetuspto-grants-2009_08
ORD IDord-f8fde40d5612458781e87e66d6018327
Source noteuspto-grants-2009_08